Tespo

About Tespo

Tespo, founded in 2013 by Ted Mills and Jeff Linton, markets a health and wellness system designed to address common issues with traditional vitamin pills, such as difficulty swallowing and the presence of unnecessary additives. The company’s core offering is a countertop dispenser that functions similarly to a single-serve coffee machine, mixing powdered vitamin formulas from proprietary pods with water to create a liquid supplement. This system is engineered to provide a pill-free alternative that enhances nutrient absorption.

The business operates on a direct-to-consumer e-commerce model, where customers purchase the dispenser and subscribe to monthly deliveries of vitamin pods. The product ecosystem consists of the Tespo Health® Dispenser, single-serving Vitamin Pods, and an accompanying mobile app. The dispenser is WiFi-connected, allowing the system to track compliance, send reminders, and adjust mixing settings based on the specific pod inserted. The pods, containing 31 servings, are sealed to maintain freshness and are formulated without sugars, GMOs, or artificial fillers. Tespo offers a range of formulas, including multivitamins for men, women, and children, as well as specialized options for energy, sleep, and bariatric patients, with the ability to create personalized vitamins based on a quiz.

Founder Ted Mills brought experience from the private investment arm of the company behind 5-Hour Energy, while Jeff Linton had a background in the durable goods equipment industry. Their collaboration began with the goal of disrupting the supplement industry's reliance on pills. Over the years, Tespo has secured significant venture capital funding, including a Series A round in 2018 and further investments to expand its digital health platform. The company has evolved its focus to become a digital health technology provider, acquiring a healthcare app and developing a platform to support the pharmacy market by monitoring medication adherence, with applications for chronic conditions like liver disease and pre-diabetes. The company was acquired in January 2023.